InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Matsui Connie, Director. Director active across 2 companies, notably Halozyme Therapeutics, INC.. Cumulatively, 8 disclosures have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €710k. History available since 5 May 2021. The latest transaction was filed on 15 October 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Matsui Connie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
50,000 股@ US$0.799100.0% 占其流量Common StockSEC:0001236537-25-000006:0
标准退出：2026年1月13日 (T+90)
10,470 股0Common StockSEC:0001415889-24-028062:0
6,501 股0Common StockSEC:0001415889-24-011698:0
8,065 股0Common StockSEC:0001415889-23-007692:0
9,250 股0Common StockSEC:0001415889-22-011512:0
6,206 股0Restricted Stock UnitsSEC:0001179110-22-002910:0
19,452 股@ US$40.126100.0% 占其流量Common StockSEC:0001179110-21-009910:0
5,230 股0Restricted Stock UnitsSEC:0001179110-21-004973:0
8 条申报中的 8 条
About Matsui Connie
Connie Matsui is a Board Member at Halozyme Therapeutics, Inc., a biopharmaceutical company. As a board member, Connie contributes to the company's governance and the development of strategies aimed at enhancing its performance. Her experience in the biopharmaceutical sector is an asset to the board.
